(Q40949888)

25 September 2017

1 reference

title

Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections (English)

1 reference

25 September 2017

Paradisi F

1

1 reference

25 September 2017

Corti G

series ordinal

2

1 reference

25 September 2017

publication date

1 August 1995

1 reference

25 September 2017

published in

Journal of Chemotherapy

1 reference

25 September 2017

volume

7

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

338-343

1 reference

What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Single-dose daily gentamicin therapy in urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Practicalities of once-daily aminoglycoside dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Once-daily aminoglycoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

A study of amikacin given once versus twice daily in serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Determinants of efficacy and toxicity of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Clinical pharmacology of antibiotics and other drugs in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

Human pharmacokinetics and distribution in various tissues of ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1995.7.4.338

21 January 2018

Identifiers

DOI

10.1179/JOC.1995.7.4.338

1 reference

25 September 2017

1 reference